Long-term administration of bisoprolol is recommended after heart attack stenting.
Long-term administration of beta-blockers, such as metoprolol, bisoprolol, carvedilol, etc., is required after heart attack stenting if there is no contraindication to the medication to reduce symptoms, improve prognosis, and reduce mortality and hospitalization rates.
Adverse effects of bisoprolol include dizziness, headache, bradycardia, syncope, bloating, and hypersensitivity. Contraindications include cardiogenic shock, sick sinus node syndrome, symptomatic hypotension, and severe bronchial asthma.
If the sudden discontinuation of bisoprolol can lead to aggravation of symptoms, reflex rapid heart rate, etc. Without special circumstances, it is not recommended to discontinue bisoprolol, bisoprolol can be replaced with metoprolol, etc.. It is necessary to use the medication under the guidance of a doctor.